Clinical Trial Update: A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of Aplidin (Plitidepsin) in advanced prostate cancer was terminated, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Aplidin (plitidepsin)

Snippet

Sponsor: PharmaMar | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-11-24